A study evaluating safety of Ranibizumab treatment for neovascular age related macular degeneration.
Latest Information Update: 16 May 2017
At a glance
- Drugs Ranibizumab (Primary)
- Indications Wet age-related macular degeneration
- Focus Adverse reactions
Most Recent Events
- 16 May 2017 New trial record